TipRanks on MSN
NRx Pharmaceuticals (NASDAQ: NRXP) Announces FDA Receipt of ANDA for KETAFREE With July 2026 Review Goal Date
Austin, Texas, United States, December 2nd, 2025, FinanceWire NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage ...
TipRanks on MSN
NRx Pharmaceuticals (NASDAQ: NRXP) amends IND to advance NRX-101 with TMS for depression treatment
Austin, Texas, United States, December 3rd, 2025, FinanceWire NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, said ...
Pharma and biotech companies have access to an unprecedented variety of health data, from electronic health records and ...
Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical ...
Putin's visit to India for the 23rd summit highlighted a new economic cooperation program aiming for $100 billion in trade by ...
AZoLifeSciences on MSN
Rentschler Biopharma and Coriolis Pharma announce strategic collaboration for integrated biopharma solutions
The collaboration unites complementary scientific and technical expertise to provide seamless solutions across the ...
PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner. MIAMI, FLORIDA / ACCESS Newswire / November ...
Mumbai: Franco India Pharmaceuticals Pvt Ltd has denied the allegations levelled against several top officials by a ...
The annual list recognizes the industry-leading companies that are the best at what they doNEW YORK--(BUSINESS WIRE)--Ostro, the leader in agentic AI omnichannel engagement platform for life sciences, ...
NORTH BETHESDA, Md., Dec. 4, 2025 /PRNewswire/ -- The International Society for Pharmaceutical Engineering (ISPE) has announced its keynote speakers for the 2026 ISPE Facilities of the Future ...
Rusfertide was generally well-tolerated through 52 Weeks of treatment. The most common treatment-emergent adverse events (AE) in rusfertide-treated patients were injection site reactions (47.4%), ...
IQVIA (NYSE: IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced a strategic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results